TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 2 | 2 | -5 | 9 | 0 | 22 | 5 |
| S | %wins | 33 | 33 | 100 | 0 | 33 | 33 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/17/14 16:04 | 3/13/14 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Williams Michelle Leroux | MD | O | Chief Sc | S.dm | -873 | 14.09 | 6 | -62 | -100 | 0 | D | 177 | 37 | -18 | -2 | -12 | -21 | -16 | -3 | 3 | -2 | -8 | 13 | -6 | 27 |
11/18/13 18:49 | 11/15/13 | OSIR | Osiris Therapeutics, Inc. | MD | Health | BioPrd | Biological Products, (No Diag | Williams Michelle Leroux | MD | O | Chief Sc | S.d | -380 | 15.50 | 7 | -25 | -100 | 0 | D | 225 | 88 | 45 | -22 | -16 | 8 | 8 | 2 | 0 | 6 | 0 | 11 | 2 | -11 |
12/11/12 17:20 | 12/11/12 | OSIR | Osiris Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Williams Michelle Leroux | MD | O | Chief Sc | S.d | -5 | 9.31 | 1 | -1 | -100 | 0 | D | 37 | 91 | 47 | -1 | -1 | 4 | -1 | -2 | 2 | 1 | -7 | 2 | 5 | 50 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |